Stephanie Davis

Stock Analyst at Barclays

(0)
# 4806
Out of 5,249 analysts
159
Total ratings
33.33%
Success rate
-22.88%
Average return
32 Stocks
Name Action Price Target Current % Upside Ratings Updated
OptimizeRx
Maintains: Equal-Weight
11 5
5.39 -7.24% 3 Nov 14, 2024
Doximity
Maintains: Overweight
52 75
55.7 34.65% 5 Nov 11, 2024
LifeStance Health Gr
Maintains: Underweight
6 7
7.99 -12.39% 2 Nov 11, 2024
GoodRx Holdings
Maintains: Overweight
10 6
4.92 21.95% 7 Nov 11, 2024
Evolent Health
Maintains: Overweight
39 19
10.15 87.19% 1 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
263 290
247.86 17% 2 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
20 24
22.28 7.72% 3 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
117 133
129.41 2.77% 2 Nov 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
39 58
43.13 34.48% 2 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
2 3
3.19 -5.96% 7 Oct 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
154 168
151.83 10.65% 3 Oct 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
1 1
1.11 -32.43% 3 Oct 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
6 5
6.89 -27.43% 10 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
213 249
244.59 1.8% 3 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
24
37.88 -36.64% 1 Jul 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
14 14
n/a n/a 6 Feb 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
12 10
n/a n/a 6 Jan 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
29
27.26 6.38% 11 Jan 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Equal-Weight
11
n/a n/a 10 Jan 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
34
10.12 235.97% 9 Feb 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
59 34
22.02 54.41% 3 Jan 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
242 233
223.21 4.39% 9 Dec 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 17
5.78 194.12% 10 Nov 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 25
n/a n/a 6 Oct 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
67 76
104.67 -27.39% 5 Jun 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
11 4
n/a n/a 7 May 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
88 95
n/a n/a 4 Dec 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
34 36
n/a n/a 4 Oct 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
45 41
29.25 40.17% 4 Aug 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 56
n/a n/a 7 May 11, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
55 53
n/a n/a 2 Feb 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
31 35
n/a n/a 2 Aug 10, 2020